383 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
AGN: RBC Capital Mkts reits Outperform http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20170925063508 Sep 25, 2017 - RBC Capital Mkts issues rating change for AGN
3 Dividend Healthcare Stocks https://www.fool.com/investing/2017/09/15/3-dividend-healthcare-stocks.aspx?source=iedfolrf0000001 Sep 15, 2017 - Looking for income from the healthcare sector? Here's why you should check out Gilead Sciences, Allergan, and LeMaitre Vascular.
A Biosimilar Cure for Sky-High Cancer Drug Prices https://www.fool.com/investing/2017/09/14/a-biosimilar-cure-for-sky-high-cancer-drug-prices.aspx?source=iedfolrf0000001 Sep 15, 2017 - The FDA has approved Amgen and Allergan's Mvasi, the first-ever cancer-drug biosimilar to win an OK.
Why Synergy Pharmaceuticals Rallied 12% Today https://www.fool.com/investing/general/2017/09/29/why-synergy-pharmaceuticals-rallied-12-today.aspx?source=iedfolrf0000001 Sep 29, 2017 - Investor presentations at conferences this week boosted optimism that Trulance is gaining market share.
AGN: Barclays reits Equal Weight http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20171002123440 Oct 02, 2017 - Barclays issues rating change for AGN
3 Big Pharma Stocks Set to Succeed https://www.fool.com/investing/2017/10/05/3-big-pharma-stocks-set-to-succeed.aspx?source=iedfolrf0000001 Oct 05, 2017 - Solid current franchises and strong pipelines could make these three big pharma stocks big winners in coming years.
Is Allergan plc a Bargain After a $7.6 Billion Dip in September? https://www.fool.com/investing/2017/10/06/is-allergan-plc-a-bargain-after-a-76-billion-dip-i.aspx?source=iedfolrf0000001 Oct 06, 2017 - Allergan continues to be a victim of Teva's downfall.
Mylan Deals a Blow to Teva Pharmaceutical https://www.fool.com/investing/2017/10/11/mylan-deals-a-blow-to-teva-pharmaceutical.aspx?source=iedfolrf0000001 Oct 11, 2017 - Mylan's latest drug approval could take a big chunk out of Teva Pharmaceutical's revenue.
3 Biotech Stocks That Soared This Week: Are They Buys? https://www.fool.com/investing/2017/10/14/3-biotech-stocks-that-soared-this-week-are-they-bu.aspx?source=iedfolrf0000001 Oct 14, 2017 - Good news from clinical studies and a scrapped acquisition help powered these biotech stocks to huge gains this week.
Allergan Inc. (AGN) Tumbled After Patent Ruling http://www.rttnews.com/story.aspx?Id=2823859 Oct 17, 2017 - Allergan Inc. (AGN) sold off sharply Monday afternoon, after the U.S. District Court for the Eastern District of Texas ruled that four asserted patents covering RESTASIS 0.05% are invalid.

Pages: 123456789101112...39

<<<Page 7>